Biocartis is a Belgium-based diagnostics company that provides testing solutions for the treatment of cancer and infectious diseases with a focus on oncology.
Business Model:
Revenue: $68.2M
Employees: 201-500
Address: Generaal de Wittelaan 11B
City: Mechelen
State: antwerp
Zip: B-2800
Country: BE
Biocartis is a Belgium-based diagnostics company that provides testing solutions for the treatment of cancer and infectious diseases with a focus on oncology.
Contact Phone:
+13215632600
Contact Email:
Listed Exchange:
NYSE Euronext
IPO Date:
4/24/2015
IPO Valuation:
$490M
Ticker Symbol:
BCART
IPO Price:
$12.504390128273297/share
Amount Raised:
$109M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2021 | Geneprodx | Series A | 3.2M |
6/2012 | Immunexpress | Venture Round | 2M |
6/2021 | Geneprodx | Series A | 0 |
6/2012 | Immunexpress | Venture Round | 0 |
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|